Bullboard - Stock Discussion Forum Agile Therapeutics Inc AGRX

Alternate Symbol(s): AGXRW

Healthcare

Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Add To Watchlist

OTCPK:AGRX - Post Discussion

Agile Therapeutics Inc > AGRX....Money talks.....Bull Feces walks

View:

Post by Iseneschal on Aug 17, 2023 10:24am

AGRX....Money talks.....Bull Feces walks

Keep making your promises with no delivery

Go Chit in a River !!!!

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter

2023-08-17 06:02 ET - News Release

PRINCETON, NJ / ACCESSWIRE / August 17, 2023 / On August 9, Agile Therapeutics (NASDAQ:AGRX) released its second-quarter financial results, showing significant growth in revenue from its innovative weekly birth control patch, Twirla® (levonorgestrel and ethinyl estradiol), and a widening gross margin thanks to net revenue growth and decreasing operating expenses. "We set single-quarter record highs in demand, net revenue and factory sales, all while reporting another quarterly decrease in operating expenses," Agile Chairperson and CEO Al Altomari said in a statement on the company's second-quarter earnings. Here are the key highlights from the latest earnings release.